EYESW (Second Sight Medical Products) Total Assets: $65.65 Mil (As of Jun. 2022)


What is Second Sight Medical Products Total Assets?

Second Sight Medical Products EYESW Total Assets is $65.65 Mil as of Jun. 2022. The stock has 1 warning sign investors should review.

Second Sight Medical Products's Total Assets for the quarter that ended in Jun. 2022 was $65.65 Mil.

During the past 12 months, Second Sight Medical Products's average Total Assets Growth Rate was 347.70% per year. During the past 3 years, the average Total Assets Growth Rate was -40.80% per year. During the past 5 years, the average Total Assets Growth Rate was -30.50% per year.

During the past 10 years, Second Sight Medical Products's highest 3-Year average Total Assets Growth Rate was 51.40%. The lowest was -42.20%. And the median was -7.60%.

Total Assets is connected with ROA %. Second Sight Medical Products's annualized ROA % for the quarter that ended in Jun. 2022 was -18.34%. Total Assets is also linked to Revenue through Asset Turnover. Second Sight Medical Products's Asset Turnover for the quarter that ended in Jun. 2022 was 0.00.

Second Sight Medical Products  (NAS:EYESW) Total Assets Explanation

Total Assets is connected with ROA %.

Second Sight Medical Products's annualized ROA % for the quarter that ended in Jun. 2022 is

ROA %=Net Income (Q: Jun. 2022 )/( (Total Assets (Q: Mar. 2022 )+Total Assets (Q: Jun. 2022 ))/ count )
=-12.304/( (68.538+65.649)/ 2 )
=-12.304/67.0935
=-18.34 %

Note: The Net Income data used here is four times the quarterly (Jun. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Second Sight Medical Products's Asset Turnover for the quarter that ended in Jun. 2022 is

Asset Turnover
=Revenue (Q: Jun. 2022 )/( (Total Assets (Q: Mar. 2022 )+Total Assets (Q: Jun. 2022 ))/ count )
=0/( (68.538+65.649)/ 2 )
=0/67.0935
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Second Sight Medical Products Total Assets Related Terms

Second Sight Medical Products Total Assets Historical Data

* Premium members only.

The historical data trend for Second Sight Medical Products's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Second Sight Medical Products Total Assets Chart

Second Sight Medical Products Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.50 10.68 16.60 4.46 70.88

Second Sight Medical Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.92 73.63 70.88 68.54 65.65

Second Sight Medical Products Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Second Sight Medical Products's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets=Total Equity (A: Dec. 2021 )+Total Liabilities (A: Dec. 2021 )
=68.365+2.514
=70.88

Second Sight Medical Products's Total Assets for the quarter that ended in Jun. 2022 is calculated as

Total Assets=Total Equity (Q: Jun. 2022 )+Total Liabilities (Q: Jun. 2022 )
=63.058+2.591
=65.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $65.65 Mil mean?
Second Sight Medical Products (EYESW) has a Total Assets of $65.65 Mil as of Jun. 2022. The total amount of assets as recorded on a company's balance sheet. View historical data on Second Sight Medical Products and its competitors.
Is Second Sight Medical Products' Total Assets too high?
Second Sight Medical Products' current Total Assets is $65.65 Mil.
How does Second Sight Medical Products' Total Assets compare to SONX and LUCD?
Second Sight Medical Products' Total Assets of $65.65 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Second Sight Medical Products and its competitors. Second Sight Medical Products's current Total Assets is $65.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Second Sight Medical Products stock overvalued right now?
Second Sight Medical Products (EYESW) has a current Total Assets of $65.65 Mil. The current Total Assets is $65.65 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Second Sight Medical Products (EYESW), the current Total Assets is $65.65 Mil as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Second Sight Medical Products Business Description

Address 13170 Telfair Avenue, Sylmar, CA, USA, 91342
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.